Device / Technology News

RSS

New MicroNav surgical technique provides greater safety and reduces pain

The revolutionary new MicroNav surgical technique, performed by Dr. Scott Hodges, gives greater safety, less pain, minimal cuts and faster recovery from spine surgery using high-tech 3D scanners and GPS-like instruments. These bold claims are backed by more than 600 surgeries with zero infections and zero revisions, a huge improvement over the high failure rate of "open" surgical techniques and questionable "laser" spine surgery.

24 May 2012

ACE’s Blood Sugar Basics Game Plan kicks off to help people with diabetes

The Blood Sugar Basics Game Plan, developed by the American College of Endocrinology (ACE), with support from Merck, is kicking off to help the nearly 26 million people in the U.S. who have diabetes find new ways to help manage their disease. Th

24 May 2012

Firefly BioWorks receives MLSC grant to commercialize new microRNA detection technology

Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.

24 May 2012

Nevro to initiate Senza HF-SCS System study for chronic pain

Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.

24 May 2012

Wound Care Center Application from MedData

MedData, Inc., a leading provider of medical revenue cycle management and patient satisfaction services, announced today the launch of a new technology that streamlines the data capture and billing process for Wound Care Physicians.

24 May 2012

Datix, UHC partner to improve patient safety and quality in U.S. hospitals

At the National Patient Safety Foundation Congress beginning today in Washington, D.C., two leaders in their respective healthcare areas have joined forces to improve patient safety.

24 May 2012

RARP more costly than RRP in treating prostate cancer

In one of the most comprehensive analyses to date of the cost of robotic-assisted, laparoscopic surgery for prostate cancer, researchers at UPMC found that this now-dominant surgical approach is significantly more costly than standard open surgery, despite little scientific evidence of long-term improved patient outcomes.

24 May 2012

LabCorp, XDx partner to develop and commercialize SLE flare predictor test

XDx, Inc. announced today that it has entered into a collaboration and license agreement with Laboratory Corporation of America Holdings (LabCorp)whereby each party will collaborate in marker discovery, and LabCorp will develop and commercialize a diagnostic test to predict flares of systemic lupus erythematosus.

24 May 2012

Zytoprotec completes PD-protec Phase I/II trial on kidney failure

Zytoprotec, a company developing drugs based on active cytoprotection, today announced the completion of a Phase I/II clinical trial with its lead product, PD-protec.

24 May 2012

Omron introduces new wireless sleep monitoring device

ResMed Inc. today announced the launch of the first product in Japan using technology from its recently acquired company, BiancaMed. The product, launched by BiancaMed partner Omron Healthcare, is a new wireless sleep monitoring device.

From ResMed Corp 24 May 2012

Viewpoints: The promise and perils of prostate screening; Presidential candidates shy away from frank discussion of spending

After an exhaustive process, the U.S. Preventive Services Task Force has announced its final recommendation on PSA-based prostate cancer screening. It finds that the known harms of screening outweigh the potential benefits for men who have no cancer symptoms. It notes that all screening studies have demonstrated considerable harms associated with screening, but only one major study found evidence that screening saves lives -- and that study has some internal inconsistencies.

24 May 2012

New liquid urine control available from Randox

The new Randox Acusera liquid urine control is designed to be both easy and convenient for laboratory staff to use. The inclusion of fully assayed target values for 18 commonly performed urine chemistry tests including Microalbumin and hCG enables consolidation and ultimately cost savings.

From Randox Laboratories Ltd. 23 May 2012

MTI develops SureTouch Wireless system for breast cancer screening

Medical Tactile, Inc. (MTI), with the support of The Pre-Mammogram Foundation and Qualcomm Incorporated, today announced that they have developed a pre-commercial SureTouch Wireless system that uses 3G-enabled tactile sensor technology for breast cancer screening.

23 May 2012

Phi29 DNA packaging nanomotor connector can aid in early disease diagnosis

A new study led by University of Kentucky researchers shows a new way to precisely detect a single chemical at extremely low concentrations and high contamination.

23 May 2012

HeartWare receives expanded European label for Ventricular Assist System

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it has received an expanded European label for long-term use of the HeartWare Ventricular Assist System in all patients at risk of death from refractory, end-stage heart failure.

23 May 2012

SOAPware releases new product that interfaces with Inmediata's PM module

SOAPware, Inc., a leading developer of certified Electronic Medical Records (EMR/EHR) and Practice Management (PM) software, is pleased to announce the release of a newly updated SOAPwareXchange product which interfaces with Inmediata's PM module.

23 May 2012

FDA clears ETView’s VivaSight-DL Airway Management System

ETView today announced that the company has received clearance of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration.

23 May 2012

FDA approves TMI’s Glider PTCA Catheter

TriReme Medical, Inc. (TMI) today announced approval by the U.S. Food and Drug Administration (FDA) of the Glider PTCA Catheter, indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion.

23 May 2012

Tri-City Medical Center leading the way with robotically enhanced spine surgery

Tri-City Medical Center, one of just 10 hospitals nationwide performing robotic spine surgery using the Mazor Renaissance guidance system, is now one of the first hospitals worldwide to use an enhancement to that system that allows surgeons to immediately verify the placement of implants, significantly diminishing the need for follow-up procedures.

23 May 2012

Federal task force recommends dropping routine prostate cancer test

The U.S. Preventive Services Task Force finds scant evidence that the PSA blood test saves lives and instead says unneeded treatment leads to serious problems, including impotence and incontinence.

23 May 2012